全文获取类型
收费全文 | 1845125篇 |
免费 | 123877篇 |
国内免费 | 3717篇 |
专业分类
耳鼻咽喉 | 26715篇 |
儿科学 | 54854篇 |
妇产科学 | 49901篇 |
基础医学 | 261549篇 |
口腔科学 | 53696篇 |
临床医学 | 155706篇 |
内科学 | 363329篇 |
皮肤病学 | 39618篇 |
神经病学 | 146619篇 |
特种医学 | 74966篇 |
外国民族医学 | 432篇 |
外科学 | 295399篇 |
综合类 | 35623篇 |
现状与发展 | 1篇 |
一般理论 | 503篇 |
预防医学 | 125575篇 |
眼科学 | 43037篇 |
药学 | 136921篇 |
3篇 | |
中国医学 | 3976篇 |
肿瘤学 | 104296篇 |
出版年
2018年 | 18911篇 |
2017年 | 14941篇 |
2016年 | 16798篇 |
2015年 | 19112篇 |
2014年 | 25653篇 |
2013年 | 38500篇 |
2012年 | 52809篇 |
2011年 | 54983篇 |
2010年 | 32932篇 |
2009年 | 31007篇 |
2008年 | 53542篇 |
2007年 | 56645篇 |
2006年 | 57518篇 |
2005年 | 56555篇 |
2004年 | 54294篇 |
2003年 | 52654篇 |
2002年 | 51727篇 |
2001年 | 92051篇 |
2000年 | 95066篇 |
1999年 | 80219篇 |
1998年 | 20520篇 |
1997年 | 18389篇 |
1996年 | 18087篇 |
1995年 | 16788篇 |
1994年 | 15846篇 |
1993年 | 14722篇 |
1992年 | 60736篇 |
1991年 | 58235篇 |
1990年 | 56640篇 |
1989年 | 54890篇 |
1988年 | 50296篇 |
1987年 | 49425篇 |
1986年 | 46560篇 |
1985年 | 44485篇 |
1984年 | 32439篇 |
1983年 | 27536篇 |
1982年 | 15484篇 |
1979年 | 29690篇 |
1978年 | 20418篇 |
1977年 | 17403篇 |
1976年 | 15705篇 |
1975年 | 17536篇 |
1974年 | 21000篇 |
1973年 | 19855篇 |
1972年 | 18958篇 |
1971年 | 17719篇 |
1970年 | 17009篇 |
1969年 | 15921篇 |
1968年 | 14823篇 |
1967年 | 13621篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
Setting goals to maintain hope. 总被引:3,自引:0,他引:3
52.
53.
Johannes Brettschneider Axel Petzold Sigurd D Süssmuth Georg B Landwehrmeyer Albert C Ludolph Jan Kassubek Hayrettin Tumani 《Movement disorders》2006,21(12):2224-2227
We aimed to evaluate the potential of the cerebrospinal fluid (CSF) axonal damage biomarker NfH(SMI35) in the laboratory-supported differential diagnosis of parkinsonian syndromes. Patients with idiopathic Parkinson's disease (PD; n = 22), multiple-system atrophy (MSA; n = 21), progressive supranuclear palsy (PSP; n = 21), corticobasal degeneration (CBD; n = 6), and age-matched controls (n = 45) were included. CSF levels of NfH(SMI35) were measured using ELISA. Levels of CSF NfH(SMI35) were elevated in PSP compared to PD and controls (P < 0.05 each). They were also significantly higher in MSA than in PD and controls (P < 0.05 each). NfH(SMI35) differentiated PD from PSP with a sensitivity of 76.5% and a specificity of 94.4%. Axonal damage as measured by CSF NfH(SMI35) is most prominent in the more rapidly progressive syndromes PSP and MSA as compared to PD or CBD. CSF NfH(SMI35) may therefore be of some value for the laboratory-supported differential diagnosis of atypical parkinsonian syndromes. 相似文献
54.
E Chankiewitz D Peschke L Herberg I Bazwinsky E Mühlbauer H-J Br?mme E Peschke 《Experimental and clinical endocrinology & diabetes》2006,114(5):262-269
The New Zealand obese mouse (NZO/Hl) is characterised by hereditary obesity and type-2 diabetes, including insulin resistance, hyperinsulinaemia, and glucose intolerance. In other diabetic models, it has been revealed that the proper functioning of the glucose transporter isoform 2 (GLUT2) is essential for adequate secretion of insulin. The aim of this study was to compare the distribution of islet cells and GLUT2, as well as the expression of GLUT2-mRNA, in the pancreas of NZO mice and metabolically unimpaired NMRI (Naval Medical Research Institute) mice. Pancreas tissue was obtained from different stages of development. For molecular determination of the expression level of GLUT2-mRNA, total-RNA was extracted from the pancreas and analysed by quantitative real-time RT-PCR. All investigated NZO mice displayed increased weight, elevated hyperinsulinaemia, and slightly enhanced blood glucose levels compared with the NMRI control mice. By means of immunofluorescence microscopy drastically reduced insulin levels were detected, which might be compensated by the observed islet cell hyperplasia and hypertrophy. Furthermore, the normally peripheral localisation of the alpha-cells within islets was disturbed. By contrast, there were no changes in somatostatin cell distribution. However, considerable differences appeared with regard to GLUT2: whereas the beta-cells of NMRI mice showed dense immunostaining of the GLUT2 transporter on the cell surface, in all age groups of NZO mice, GLUT2 on the plasma membranes was reduced and dispersed in the cytoplasm. These findings agree with the molecular biological results, which displayed decreased mRNA-expression of GLUT2. In summary, the observed alteration of islet morphology and of GLUT2 expression in diabetic mice complements our previous results from a superfusion protocol and further clarifies the mechanisms of diabetogenesis in NZO mice. 相似文献
55.
F Lofaso F Nicot M Lejaille L Falaize A Louis A Clement J-C Raphael D Orlikowski B Fauroux 《The European respiratory journal》2006,27(5):980-982
Sniff nasal inspiratory pressure (SNIP) measurement is a volitional noninvasive assessment of inspiratory muscle strength. A maximum of 10 sniffs is generally used. The purpose of the present study was to investigate whether the maximum SNIP improved after the tenth sniff. In total, 20 healthy volunteers and 305 patients with various neuromuscular and lung diseases were encouraged to perform 40 and 20 sniffs, respectively. The best SNIP among the first 10 sniffs was lower than the best SNIP among the next 10 sniffs in the healthy volunteers and patients. The SNIP improvement after the twentieth sniff was marginal. In conclusion, a learning effect persists after the tenth sniff. The current authors suggest using 10 additional sniffs when the best result of the first 10 sniffs is slightly below normal, or when sniff nasal inspiratory pressure is used to monitor a progressive decline in inspiratory muscle strength. 相似文献
56.
J Phua E S C Koay D Zhang L K Tai X L Boo K C Lim T K Lim 《The European respiratory journal》2006,28(4):695-702
Levels of the soluble form of the triggering receptor expressed on myeloid cells (sTREM)-1 are elevated in severe sepsis. However, it is not known whether sTREM-1 measurements can distinguish milder bacterial infections from noninfectious inflammation. The present authors studied whether serum sTREM-1 levels differ in community-acquired pneumonia, exacerbations of chronic obstructive pulmonary disease (COPD), asthma and controls, and whether sTREM-1 may be used as a surrogate marker for the need for antibiotics. Serum sTREM-1 levels in 150 patients with pneumonia, COPD and asthma exacerbations and 62 healthy controls were measured. Serum sTREM-1 levels were significantly elevated in pneumonia (median 295.2 ng x mL(-1)), COPD (280.3 ng x mL(-1)) and asthma exacerbations (184.0 ng x mL(-1)) compared with controls (83.1 ng x mL(-1)). Levels were higher in pneumonia and Anthonisen type 1 COPD exacerbations than in type 2 and 3 COPD and asthma exacerbations. The area under the receiver operating characteristics curve for sTREM-1 as a surrogate marker for the need for antibiotics was 0.77. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 were elevated predominantly in pneumonia and Anthonisen type 1 COPD exacerbations versus type 2 and 3 chronic obstructive pulmonary disease exacerbations, asthma and controls. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 has moderate but insufficient accuracy as a surrogate marker for the need for antibiotics in lower respiratory tract infections. 相似文献
57.
58.
59.
60.
Patricia A Wilkosz Sachiko Miyahara Oscar L Lopez Steven T Dekosky Robert A Sweet 《The American journal of geriatric psychiatry》2006,14(4):352-360
BACKGROUND: Psychotic symptoms in Alzheimer disease (AD+P) identify a heritable phenotype associated with more rapid cognitive decline. The authors have proposed that AD+P is itself a composite of a misidentification and a paranoid subtype with increased cognitive impairment restricted to the misidentification type. Most prior studies of the clinical correlates of AD+P have been limited, however, by the inclusion of prevalent cases. METHODS: Subjects with possible or probable AD or mild cognitive impairment (MCI) without psychosis at study entry were assessed at the time of initial presentation and then annually. Psychotic symptoms were assessed using the CERAD Behavioral Rating Scale. Survival analyses used Cox proportional hazard models with time-dependent covariates to examine the predictors of psychosis onset. RESULTS: A total of 288 subjects completed at least one follow-up examination. Mean duration of follow-up was 22.1 months. The incidence of psychosis was 0.19 per person-year. Cognitive impairment was associated with onset of psychosis, largely as a result of its association with onset of the misidentification, but not the paranoid, subtype. Including psychotropic medication use in the model revealed an association of antidepressant use with the onset of psychosis. This latter association appeared to arise from an underlying association between depression and the risk of psychosis onset rather than from antidepressant treatment. CONCLUSION: These findings are consistent with the hypothesis that the misidentification and the paranoid subtypes each define a more biologically homogeneous group than AD+P as a whole. Further exploration of the relationship between depressive symptoms and psychosis in patients with AD is warranted. 相似文献